Location: Home
  • search
  • go
  • Relate News
  • 3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...
  • 3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations
  • 3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor
  • 3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report
  • 3/22/2021Bayer Launches Prostate Cancer Drugs Nubeqa and Xofigo in China
  • 3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum
  • 3/19/2021Recent Executive Moves
  • 3/18/2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC...
  • 3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...
  • 3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection
  • 3/18/2021Ping An Good Doctor: Cross-Sectional Survey
  • 3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...
  • 3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...
  • 3/16/2021Chinese Chemical Drug Manufacturing Industry Revenue Down Slightly in ...
  • 3/16/2021Italfarmaco Group Agreed with Luye Pharma to Commercialize Rivastigmi...
  • 3/16/2021Pfizer to Halt Biosimilar Production in China and Sell Its Hangzhou Bi...
  • 3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept
  • 3/16/2021BeiGene Announces Acceptance of a Supplemental Biologics License Appli...
  • 3/16/2021Patent Term Extension in China
  • 3/15/2021Highlights of the 14th Five Year Plan Covers Various Aspects of Health...
  • 3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes
  • 3/12/2021Recent Executive Moves
  • 3/11/2021NHSA Initiates DRG-based Medical Insurance Payment in Simulation Run
  • 3/10/2021Alphamab's IND for Phase II Pivotal Trial of KN046 Cleared in the U.S...
  • 3/10/2021Wugen Enter Partnership with Alpha Biopharma in Asia for Cell Therapie...
  • 3/10/2021I-Mab Signs Two New Partnerships to Expand Transformational I/O Pip...
  • 3/10/2021ReForm Biologics Announces the Issuance of Chinese Patent for Therapeu...
  • 3/10/2021Multi-source Financing for Tuberculosis Treatment in China: Key Issues...
  • 3/10/2021I-Mab BioPharma and Its Dual Drug Portfolio
  • 3/9/2021Sinopharm Faces Battle to Turn Covid Vaccine into a Global Success
  • Page:71/333 Total number of articles:9989: [First][<<] [69] [70] [71] [72] [73] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group